Secondary Analyses in Obesity, Diabetes, Digestive and Kidney Diseases (R21)
National Institutes of Health · Opportunity PA-06-151
Multiple Receipt Dates - See Link to Full Announcement for details.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities
- Native American tribal organizations (other)
- Nonprofits with 501(c)(3), other than higher education
- Nonprofits without 501(c)(3)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Others
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
About this opportunity
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications to support the secondary analysis of existing data sets relevant to diabetes and endocrine and metabolic diseases; digestive diseases and nutrition, including obesity and eating disorders; and kidney, urological, and hematological diseases. A major subject of this announcement is the support of research on overweight and obesity. The goal of this NIDDK program is to facilitate performance of short term projects that explore innovative approaches that are not readily supported by other funding mechanisms and that can be conducted using existing data sets.
Similar grants still open
| Opportunity | Agency | Deadline | Award ceiling | Eligible |
|---|---|---|---|---|
| Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required) | National Institutes of Health | October 6, 2026 | — | Nonprofits |
| Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional) | National Institutes of Health | November 5, 2027 | — | Nonprofits |
| Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed) | National Institutes of Health | November 16, 2027 | — | Nonprofits |
| Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) | National Institutes of Health | January 6, 2028 | — | Nonprofits |